DrugPatentWatch Database Preview
Details for Patent: 7,731,989
Which drugs does patent 7,731,989 protect, and when does it expire?
Patent 7,731,989 protects GRALISE and is included in one NDA.
This patent has twenty-four patent family members in nine countries.
Summary for Patent: 7,731,989
| Title: | Gastric retained gabapentin dosage form |
| Abstract: | A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. |
| Inventor(s): | Berner; Bret (El Granada, CA), Hou; Sui Yuen Eddie (Foster City, CA), Gusler; Gloria M. (Cupertino, CA) |
| Assignee: | Depomed, Inc. (Menlo Park, CA) |
| Application Number: | 12/239,591 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,731,989 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Formulation; |
Drugs Protected by US Patent 7,731,989
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-001 | Jan 28, 2011 | BX | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-002 | Jan 28, 2011 | BX | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,731,989
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2002348828 | Start Trial | |||
| Australia | 2005267738 | Start Trial | |||
| Australia | 2006332690 | Start Trial | |||
| Canada | 2464322 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
